Sort
25,944 grants matching “neurodegeneration”
Leucine as a Probe of Kynurenine-Induced Glutamate and Neural Circuit Dysfunction in Midlife Depression
$688,776Ebrahim Haroon · Emory University · R01 · FY2025 · MH
Discovery of Biomarkers in Human Mitochondrial Diseases
$688,662Ronald Wayne Davis · Stanford University · R01 · FY2006 · EY
Neurotoxicity of particulate matter and its interaction with APOE in neurodegeneration
$688,560Masashi Kitazawa · University Of California-Irvine · R01 · FY2025 · NS
A Transgenic Monkey: Inherited Neurodegenerative Disease
$688,435Anthony Wing Sang Chan · Emory University · R24 · FY2007 · RR
Cyclic EphA4 peptide antagonists for neuroprotection in ALS
$688,311Elena B Pasquale · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2016 · NS
Mitigating neuroinflammation and enhancing neuronal integrity in Alzheimer's disease
$688,260Jianjie Ma · University Of Virginia · R01 · FY2022 · AG
Mitigating neuroinflammation and enhancing neuronal integrity in Alzheimer's disease
$688,153Jianjie Ma · University Of Virginia · R01 · FY2023 · AG
Discovery of Biomarkers in Human Mitochondrial Diseases
$688,052Ronald Wayne Davis · Stanford University · R01 · FY2008 · EY
Mitigating neuroinflammation and enhancing neuronal integrity in Alzheimer's disease
$688,045Jianjie Ma · University Of Virginia · R01 · FY2024 · AG
Studying the pathogenic roles of human CD8+ T cells in Alzheimer's disease using a 3D human Peripheral immune Chip.
$688,000Doo Yeon Kim · Massachusetts General Hospital · R01 · FY2024 · AG
Memory Circuitry in MCI and Early Alzheimerâs Disease Prodrome: Molecular Drivers
$687,972Andrew J Saykin · Indiana University Indianapolis · R01 · FY2017 · AG
Treating primary progressive aphasia and elucidating neurodegeneration in the language network using transcranial direct current stimulation
$687,913Roy H Hamilton · University Of Pennsylvania · R01 · FY2024 · AG
Leucine as a Probe of Kynurenine-Induced Glutamate and Neural Circuit Dysfunction in Midlife Depression
$687,736Ebrahim Haroon · Emory University · R01 · FY2023 · MH
Identify common mechanisms of neurodegeneration between Alzheimer's disease and Down syndrome
$687,475Ramon Velazquez · Arizona State University-Tempe Campus · R01 · FY2020 · AG
Neuronal Autophagy: a Cell-Autonomous Protection Mechanism
$687,361Zhenyu Yue · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · NS
Neurodegeneration and Brain Function in Aging with HIV and Parkinson's Disease
$687,174Tilman Schulte · Sri International · R01 · FY2014 · AA
Leveraging Neuroimaging Biomarkers to Understand the Role of Social Networks in Alzheimer's Disease
$687,133Brea Louise Perry · Trustees Of Indiana University · R01 · FY2020 · AG
The role of Alzheimer's disease GWAS risk factor BIN1 in tau neuropathology and propagation in vivo
$686,781Gopal Thinakaran · University Of South Florida · R01 · FY2025 · AG
Validating Secretory Autophagy as a Therapeutic Strategy for Diverse Forms of ALS and FTD
$686,752Justin Kawika Ichida · University Of Southern California · R01 · FY2023 · NS
Validating Secretory Autophagy as a Therapeutic Strategy for Diverse Forms of ALS and FTD
$686,752Justin Kawika Ichida · University Of Southern California · R01 · FY2024 · NS
Use of High Density Lipoprotein Proteome in the Prediction of Cognitive Impairment and Alzheimer's Disease: (REGARDS)
$686,541Robert Sidney Rosenson · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · AG
Relaxivity Contrast Imaging as Biomarker of Muscle Degeneration in ALS
$686,517Christopher Chad Quarles · University Of Tx Md Anderson Can Ctr · R61 · FY2023 · NS
Discovery of functionally selective Alzheimer's disease therapeutics
$686,442Derek A Schreihofer · University Of North Texas Hlth Sci Ctr · R01 · FY2021 · AG
Identification of novel four repeat tauopathies through analysis of network vulnerability, tau structure and propagation.
$686,297Ruben Vidal · Indiana University Indianapolis · R01 · FY2023 · AG
The Alzheimer's Disease Resiliome: Pathway Analysis and Drug Discovery.
$686,190Rudolph Emile Tanzi · Massachusetts General Hospital · R01 · FY2019 · AG